China Releases New Guidelines For Drug And Device Price Reforms
This article was originally published in PharmAsia News
SHANGHAI - China's top economic planner, the National Development and Reform Commission together with the Ministry Of Health and the Ministry of Human Resources and Social Security released Nov. 23 a new guideline to further reform pricing measures for drugs and devices
You may also be interested in...
SHANGHAI - China's National Development and Reform Commission issued Oct. 2 a guideline price for its Essential Drug List, which stipulates price ceilings for 296 drugs on the first part of the list
SHANGHAI - China's Ministry Of Health released Aug. 18 the first part of the essential drug list for community health organizations, which consists of 205 chemical drugs and biologics as well as 102 traditional Chinese Medicines. The implementation will begin Sept. 21 in 30 percent of the government-run low-tier hospitals and clinics
SHANGHAI- China's medical device market has reached RMB 83 billion ($12.1 billion), roughly one-eighth of the total healthcare industry, according to a report by Frost & Sullivan